title: Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico.
abstract: BACKGROUND
  Under normal conditions, the expression of CD14, which is the principal receptor for bacterial lipopolysaccharide, is down-regulated in the intestinal mucosa but increases in response to inflammatory stimuli. The aim of the present study was to investigate whether fecal CD14 levels increased in response to infection with diarrheagenic Escherichia coli and whether single nucleotide polymorphisms (SNPs) in the CD14 gene were associated with an increased susceptibility to traveler's diarrhea (TD) in US visitors to Mexico.
  
  
  METHODS
  Six SNPs located at the promoter, exon, and untranslated regions of CD14 were typed in a prospective cohort study of 1360 visitors to Mexico at risk for TD. Stools from visitors with TD were studied for enteric pathogens by culture, colony hybridization, and polymerase chain reaction. Fecal soluble CD14 (sCD14) was measured in a subgroup of 203 adults with diarrhea and 66 healthy controls by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  The minor allele frequencies for CD14 SNPs were significantly different among the various racial and ethnic groups studied. Two SNPs in the promoter region of CD14 (-159 C > T; rs2569190 and -4191 C > T; rs5744441) were found to be associated with TD in White visitors. The -159 TT genotype was associated with a higher risk for TD (Relative risk [RR], 1.21; 95% confidence interval [CI], 1.05-1.38; P = .008), whereas individuals with the -4191 TT genotype were protected from infection (RR, 0.82; 95% CI, 0.71-0.92; P = .006). Subjects with TD excreted higher levels of fecal CD14 than did healthy controls (33,480 pg/mL vs 6178 pg/mL; P < .02). Fecal sCD14 levels were higher in stool samples from visitors with TD and the -159 TT genotype than they were in visitors with the CC/CT genotypes (P = .02), and stool samples from subjects with the -4191 CC genotype had higher fecal sCD14 levels than did stool samples from visitors with the CT/TT (P = .005) genotype. In a multivariate analysis with haplotypes constructed with the 6 SNPs studied, subjects with the haplotype containing the -159 C and the -4191 T allele were less likely to acquire TD (P = .015).
  
  
  CONCLUSIONS
  Our study suggests that CD14 levels increase in response to bacterial diarrhea and that polymorphisms in the CD14 gene influence susceptibility to TD. Intestinal CD14 plays an important role in the innate immune response to enteric pathogens.
authors: Department of Internal Medicine, Division of Infectious Diseases University of Texas Medical School at Houston, Houston, TX 77030, USA.
authors: Jamal A
authors: JA
authors: Mohamed
authors: Herbert L
authors: HL
authors: DuPont
authors: Jose
authors: J
authors: Flores
authors: Himaja
authors: H
authors: Palur
authors: Parvathy
authors: P
authors: Nair
authors: Zhi-Dong
authors: ZD
authors: Jiang
authors: Dongchuan
authors: D
authors: Guo
authors: Jaime
authors: J
authors: Belkind-Gerson
authors: Pablo C
authors: PC
authors: Okhuysen
references: J Infect Dis. 2009 Feb 15;199(4):477-85
references: 19128145
references: J Exp Med. 2000 May 15;191(10):1807-12
references: 10811873
references: J Hepatol. 1995 Oct;23(4):396-402
references: 8655956
references: Infect Immun. 2000 Dec;68(12):6519-25
references: 11083760
references: Infect Immun. 2003 Aug;71(8):4808-14
references: 12874365
references: Infect Immun. 1995 Dec;63(12):4721-8
references: 7591128
references: J Allergy Clin Immunol. 2005 May;115(5):1056-62
references: 15867866
references: J Clin Microbiol. 2007 Jan;45(1):121-6
references: 17093030
references: J Med Genet. 2003 Sep;40(9):e108
references: 12960224
references: Clin Exp Allergy. 2008 Dec;38(12):1929-34
references: 19037967
references: Chest. 1995 Dec;108(6):1614-6
references: 7497770
references: J Endotoxin Res. 2001;7(1):45-8
references: 11521081
references: Scand J Gastroenterol. 2002 Jun;37(6):699-704
references: 12126249
references: Am J Respir Cell Mol Biol. 2004 Aug;31(2):162-70
references: 15059784
references: J Endotoxin Res. 2001;7(6):442-6
references: 11753214
references: J Immunol. 2001 Nov 15;167(10):5838-44
references: 11698458
references: J Immunol. 1990 Jul 1;145(1):331-6
references: 1694207
references: Am J Respir Crit Care Med. 2006 Aug 15;174(4):365-6
references: 16894017
references: Clin Infect Dis. 2005 Dec 1;41 Suppl 8:S571-6
references: 16267721
references: J Med Microbiol. 2007 Oct;56(Pt 10):1386-1392
references: 17893178
references: Oral Dis. 2009 Oct;15(7):484-9
references: 19500269
references: Clin Cancer Res. 2007 Apr 15;13(8):2362-8
references: 17438094
references: Clin Vaccine Immunol. 2008 Aug;15(8):1194-8
references: 18579697
references: Arch Dermatol Res. 1992;284(6):339-42
references: 1284103
references: J Infect Dis. 1986 Mar;153(3):527-34
references: 3512729
references: J Am Coll Cardiol. 2002 Jul 3;40(1):34-42
references: 12103253
references: Science. 1990 Sep 21;249(4975):1431-3
references: 1698311
references: Immunity. 1994 Sep;1(6):509-16
references: 7534618
references: Scand J Gastroenterol. 2002 Feb;37(2):189-91
references: 11843056
references: J Infect Dis. 1987 Apr;155(4):809-11
references: 3546524
references: Biochim Biophys Acta. 2006 Jan;1762(1):1-16
references: 16185850
references: J Infect Dis. 2003 Aug 15;188(4):506-11
references: 12898436
references: Clin Diagn Lab Immunol. 1995 Jan;2(1):10-3
references: 7719900
references: J Immunol. 1995 Jun 15;154(12):6529-32
references: 7539025
references: Exp Cell Res. 2006 Oct 15;312(17):3276-86
references: 16860318
references: Crit Care Med. 2005 Mar;33(3):638-44
references: 15753758
references: J Clin Invest. 1988 Nov;82(5):1714-21
references: 3183065
references: Crit Care Med. 2003 Mar;31(3):929-32
references: 12627007
references: Jpn J Infect Dis. 2005 Feb;58(1):11-4
references: 15728983
references: Prog Clin Biol Res. 1995;392:349-51
references: 8524940
references: J Med Microbiol. 2000 Jan;49(1):97-101
references: 10628831
references: Science. 1988 Jan 29;239(4839):497-500
references: 2448876
references: Clin Infect Dis. 2007 Apr 1;44(7):945-52
references: 17342646
references: Clin Diagn Lab Immunol. 2003 Mar;10(2):286-92
references: 12626456